| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |